FREE Account Opening + No Clearing Fees
Loading...

Angel One IPO vs Gland Pharma IPO

Comparision between Angel One IPO and Gland Pharma IPO.

IPO Details

Angel One IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Angel One IPO is up to ₹600.00 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Angel One IPO is ₹306.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.

  Angel One IPO Gland Pharma IPO
Face Value ₹10 per share ₹1 per share
Issue Price (Lower) ₹305.00 per share ₹1,490.00 per share
Issue Price (Upper) ₹306.00 per share ₹1,500.00 per share
Issue Price (Final) ₹306.00 per share ₹1,500.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 49 shares 10 shares
Fresh Issue Size 83,33,333 shares
Fresh Issue Size (Amount) up to ₹300.00 Cr up to ₹1,250.00 Cr
OFS Issue Size 3,48,63,635 shares
OFS Issue Size (Amount) up to ₹300.00 Cr up to ₹5,229.55 Cr
Issue Size Total 4,31,96,968 shares
Issue Size Total (Amount) up to ₹600.00 Cr up to ₹6,479.55 Cr

IPO Timetable

Angel One IPO opens on Sep 22, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Angel One IPO and Gland Pharma IPO is Sep 24, 2020, and Nov 11, 2020, respectively.

  Angel One IPO Gland Pharma IPO
Anchor Bid Date
Issue Open Sep 22, 2020 Nov 09, 2020
Issue Close Sep 24, 2020 Nov 11, 2020
Basis Of Allotment (Tentative) Sep 29, 2020 Nov 17, 2020
Initiation of Refunds (Tentative) Sep 30, 2020 Nov 18, 2020
Credit of Share (Tentative) Oct 01, 2020 Nov 19, 2020
Listing date (Tentative) Oct 05, 2020 Nov 20, 2020
Anchor Lockin End date 1 Oct 29, 2020 Dec 17, 2020
Anchor Lockin End date 2 Dec 28, 2020 Feb 15, 2021

Financials

Angel One IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .

  Angel One IPO Gland Pharma IPO
Financial

Summary of financial Information (Restated)

Particulars For the year/period ended (Rs in Million)
30 June 2020 31 March 2020 31 March 2019 31 March 2018
Total Assets 29,731.02 21,592.05 21,690.56 22,828.67
Total Revenue 2,440.86 7,427.79 7,626.47 7,536.55
Profit After Tax 381.83 866.24 766.94 1,010.52
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 46,912.65 40,860.39 35,235.49 29,294.68
Total Revenue 9,162.89 27,724.08 21,297.67 16,716.82
Profit After Tax 3,135.90 7,728.58 4,518.56 3,210.51
Promoter Shareholding (Pre-Issue) 65.42% 74%
Promoter Shareholding (Post-Issue) 58%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Angel One IPO retail investors (RII) are offered 68,85,246 shares while in Gland Pharma IPO retail investors are offered 68,85,246 shares. Qualified institutional buyers (QIB) are offered 39,34,425 shares in Angel One IPO and 86,39,394 shares in Gland Pharma IPO.

  Angel One IPO Gland Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 39,34,425 shares 86,39,394 shares
NII 29,50,820 shares 64,79,546 shares
RII 68,85,246 shares 1,51,18,939 shares
Employee 0 shares 0 shares
Others
Total 1,37,70,491 shares 3,02,37,879 shares

Bids Received (Subscription)

Angel One IPO subscribed 3.94x in total, whereas Gland Pharma IPO subscribed 2.06x.

  Angel One IPO Gland Pharma IPO
QIB (times) 5.74x 6.40x
NII (times) 0.69x 0.51x
Big NII (times)
Small NII (times)
RII (times) 4.31x 0.24x
Employee (times)
Other (times)
Total (times) 3.94x 2.06x

Comments

Add a public comment...